IDRIA B
Additive-free, injectable platelet-rich fibrin prepared from whole blood in a short, single-spin process. Designed for routine clinical workflows and fine-gauge injection.
PRODUCT OVERVIEW
IDRIA B is a no-anticoagulant, no-gel tube system for preparing injectable PRF (iPRF) at the point of care. A short, low-rcf centrifugation concentrates platelets and leukocytes in plasma. After injection, the fibrin network polymerizes in situ, forming a soft matrix.
Use is at clinician discretion and subject to local regulation.
Idria B retains the fluid nature of platelet-rich plasma while predominantly having mononuclear cells and a concentrated reservoir of growth factors. Compared to baseline whole blood, it delivers a significantly higher platelet concentration , which directly enhances the release of bioactive proteins such as PDGF, VEGF, TGF-β, and EGF. These preparations contain platelet-derived factors associated with angiogenesis, collagen remodeling, and follicular stimulation; clinical application remains at the discretion of the physician.
With minimal instrumentation and materials required, Idria B offers a cost-effective solution for volumetric and Its optimized single 4-minute spin process yields a highly concentrated mix of regenerative cells and signaling proteins.
WHY IDRIA B
ADDITIVE-FREE
No anticoagulants, activators, or gels
SIMPLE & FAST
Short single-spin protocol designed for everyday practice
INJECTABLE
Suitable for fine-gauge delivery before clot formation
CONSISTENT
Closed tube and defined time/force/volume parameters
HOW IT WORKS
DRAW
30 mL whole blood directly into IDRIA B tubes (no anticoagulant).
CENTRIFUGE
Using the specified low-rcf, short-time protocol (see IFU).
RECOVER iPRF
Promptly and inject within the working time per IFU to allow in-situ fibrin polymerization.
TECHNICAL SNAPSHOT*
INPUT
30 mL whole blood (per IFU volume)
PROCESS
Single, short spin at low rcf (×g)
OUTPUT
Injectable PRF (platelets + leukocytes in plasma) with a short working time prior to gelation
* Operational parameters and yields vary by technique, equipment, and donor factors. Refer to the product IFU.
Design
Closed tube workflow — for in-process integrity
Additive-free formulation — to preserve autologous character
Protocol clarity — defined timing to support predictable handling and injection
VERSATILITY
INJECTABLE
For clinician-directed protocols
GELLABLE IN SITU
(Soft fibrin matrix)
MIXABLE WITH SCAFFOLDS OR GRAFTS
Where permitted by local practice and regulation
AREAS OF CLINICAL USE
At clinician discretion, iPRF is used across:
AESTHETIC DERMATOLOGY & HAIR
DENTAL/ORAL SURGERY
PLASTIC & RECONSTRUCTIVE
ORTHOPEDICS & SPORTS MEDICINE
WOUND CARE
Permitted uses and availability vary by country; follow local regulations and guidelines
Quality &
- Parameters defined: time/rcf/volumes and working-time guidance
- Documentation: IFU/SOP, QC & batch templates, traceability
- Labeling: multilingual inserts/labels where applicable
IMPORTANT INFORMATION
The product is CE marked, certifying compliance with the essential requirements of European legislation governing medical devices. For professional use only. Product availability, regulatory status, and indications vary by market. Consult the IFU and local regulations before use.
Kit
IDRIA B (30 ML) tube (injectable PRF)
Blood-draw accessories (by configuration)
Quick protocol card + IFU
